Egalet reports topline results from bioequivalence studies of abuse-deterrent morphine
Study 067-EG-005 evaluated the area under the curve (AUC) and the maximum or peak plasma concentration (Cmax) of Egalet-001 100 mg versus the same dose of MS Contin